Ignite Creation Date:
2025-12-24 @ 1:16 PM
Ignite Modification Date:
2026-02-24 @ 10:44 AM
Study NCT ID:
NCT02680795
Status:
COMPLETED
Last Update Posted:
2025-10-17
First Post:
2016-02-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes
Sponsor:
Acrotech Biopharma Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SPI-BEL-106
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None